Before comparing cranberry ingredient quotations, ask each supplier to complete the same description: material type, PAC fraction, analytical procedure, reference standard and reporting basis. A percentage without those details leaves the buyer to guess whether two offers describe the same quantity.
The purchase decision has three parts: identify the material, agree how its proanthocyanidins (PACs) will be measured, and confirm the result in the intended finished product. This article focuses on that analytical and purchasing task, not on selecting a clinical dose.
Start with the material, not the headline percentage
A study published online in May 2026 examined 53 US cranberry dietary supplements made with extracts, concentrates or whole-fruit powders.[1][6] Four commercial laboratories measured soluble PAC using harmonized extraction solvents but their own DMAC workflows; all four used procyanidin A2 as a reference standard, and two also used a cranberry PAC standard.[1] Insoluble PAC was measured separately, by a butanol–hydrochloric acid assay in one laboratory.[1]
That distinction matters. In this sample, concentrate- and fruit-powder-based products contained more insoluble PAC than extract-based products.[1] A soluble-PAC specification therefore addresses a particular fraction, not the complete composition of every cranberry material.
The extract-based products also had a higher average soluble-PAC amount per daily intake than concentrate-based products; the comparison with whole-fruit-powder products was not statistically significant.[1] These are finished-supplement comparisons on a daily-intake basis, not a ranking of ingredient purity or a head-to-head test of equal ingredient weights.
For an inquiry, specify whether the project needs fruit powder, concentrate or extract. Request the botanical species and plant part, the manufacturing route, any carriers and their proportions, and the basis used for the quoted PAC percentage. In particular, establish whether the result describes the material as supplied or a dry-matter basis. That gives procurement and the laboratory a common starting point.
Turn “DMAC” into an agreed testing procedure
A method-validation study compared procyanidin A2 and cranberry PAC reference standards in four test materials: cranberry fiber powder, cranberry extract powder, concentrated cranberry juice and a cranberry-PAC solution.[4] Its abstract reports that repeatability met the specified performance requirements and that interlaboratory Horwitz ratios met the cited acceptance range for both standards; the authors favored the cranberry PAC standard.[4]
Validation under a defined procedure is different from agreement between laboratories using their routine workflows. In the 2026 study, interlaboratory relative standard deviations for in-house controls and products containing more than 3.3 mg/day PAC ranged from 22.1% to 31.6%.[1] That range describes the study’s analytical variability; it is not a supplier acceptance tolerance.
Before making a PAC result contractual, ask the testing laboratories to agree on:
- The sample preparation and extraction procedure, with the method name and version.
- The reference standard and how the result is expressed against it.
- Whether the target is soluble PAC, and the reporting units and moisture basis.
- The reporting or quantification limit, sampling plan and replicate scheme.
- The acceptance criteria and the procedure for investigating discrepant results.
A shared, representative sample is a useful starting point for this comparison. Have both laboratories report the preparation steps and calculations as well as the final number. If their methods differ, resolve that difference before applying a common release limit. Do not insert a universal A2-to-cranberry-standard multiplier into the specification: the cited studies do not establish one that applies across materials and workflows.
Read the denominator: three historical product results
A 2020 study measured PAC in 24 cranberry-labelled supplements using BL-DMAC.[2] Table 2 reports results per dosage unit, with means and standard deviations from three replicates and external calibration using an A-type PAC dimer.[2] Those replicates should not be read as three independent production batches.
The three selected rows below all list BL-DMAC as the method declared by the manufacturer.[2] The last column is recalculated from the published means and declarations, not from new laboratory testing.
| Study sample | Declared PAC, mg per dosage unit | Measured PAC, mg per dosage unit, mean ± SD | Measured ÷ declared × 100 |
|---|---|---|---|
| #4 | 36 | 34.86 ± 1.73 | 96.83% |
| #6 | 36 | 4.91 ± 0.22 | 13.64% |
| #24 | 36 | 37.17 ± 1.53 | 103.25% |
Source: Table 2; percentage column recalculated.[2]
The source labels its percentage column “%CV” and describes it as a percentage difference, but the values actually reproduce measured content as a percentage of declared content.[2] They are neither conventional coefficients of variation nor percentage shortfalls. For example, sample #4’s measured-to-declared ratio is 96.83%, its calculated shortfall is 3.17%, and SD divided by the measured mean gives a replicate CV of approximately 4.96%.
The paper also has conflicting descriptions: its text lists eight BL-DMAC-labelled products while the table lists nine, and sample #9 is called “85% lower” even though the table reports 37.89 mg against 45 mg declared.[2] Those numbers imply 84.20% of the declaration, or a 15.80% shortfall. The selected rows are useful examples of certificate comparison, not a current-market failure rate or a reason to attribute a new supplier’s discrepancy to a particular cause.
For a daily-intake target, add one more check: multiply the result per unit by the stated number of units per day. A capsule, sachet or other dosage unit is not automatically a daily serving.
Separate identity evidence from content evidence
The 2020 investigators also compared anthocyanin fingerprints with authentic Vaccinium macrocarpon fruit, using HPLC-UV/Vis and UHPLC–mass spectrometry.[2] PAC measurement and botanical fingerprinting were separate parts of the investigation.
Ask the supplier and testing laboratory to explain how their identity method fits the purchased material and its extraction or purification history. If a pigment signal is absent, request an interpretation appropriate to that process rather than treating the absence alone as a counterfeit verdict. Likewise, if the specification calls for a particular A-type structure, request evidence that measures that feature; a report headed only “PAC” does not answer the structural question.
Compare cost only after the analytical basis matches
Consider a hypothetical ingredient priced at USD 100/kg, with a verified 10% soluble-PAC result on the as-supplied basis under the agreed method:
- Assay-reported PAC per kilogram: 1,000 g × 10% = 100 g.
- Ingredient cost per gram of assay-reported PAC: USD 100 ÷ 100 g = USD 1/g.
This is a costing example, not a market quotation. It compares the quantity reported by the agreed assay; it does not calculate absorbed PAC or clinical benefit.
Use this metric only between technically qualified offers. A 20% result obtained by a different procedure is not automatically twice the same purchased quantity. Compare carrier load, flavor, processing behavior, testing costs and performance in the intended dosage form alongside the PAC-based cost.
Finally, verify the finished product rather than assuming an ingredient certificate settles the result after formulation. Among 14 products declaring PAC content, the USDA record of the 2026 study reports a mean measured-versus-declared difference of −32%, with an SD of 51.4%.[1] This is a summary of those 14 products, not a uniform 32% loss or evidence of what caused any discrepancy.
For a productive sourcing discussion, send the intended material category, destination market, dosage form, analytical target and expected supporting documents together. Agree the material and test first, compare qualified prices second, and confirm the finished-product target before release.
Evidence scope
The 2026 findings above come from the USDA author-institution record and the indexed journal abstract; the method-validation findings are also abstract-level.[1][4][6] The 2020 table and methods were checked against the full paper.[2] The purchasing steps and cost example are editorial recommendations, not laboratory results or supplier promises.
Sources
[1] USDA ARS 2026 multi-lab cranberry PAC study
[2] 2020 cranberry supplement QC primary study
[4] Cranberry DMAC inter-laboratory validation: abstract
[6] 2026-europepmc